Search results
Results from the WOW.Com Content Network
In men, high levels of prolactin can result in a number of intimate problems, including: (ED) Reduced libido. Decreased fertility. Cabergoline is a dopamine agonist. It works to reduce the amount ...
Unlike women, who most commonly have microprolactinomas, men usually present with macroprolactinomas, and their serum prolactin levels are generally much higher than those observed in women. [ 13 ] Long-term hyperprolactinaemia can lead to detrimental changes in bone metabolism as a result of hypoestrogenism and hypoandrogenism .
Prolactin inhibitors are mainly used to treat hyperprolactinemia (high prolactin levels). [1] Agonists of the dopamine D 2 receptor such as bromocriptine and cabergoline are able to strongly suppress pituitary prolactin secretion and thereby decrease circulating prolactin levels, and so are most commonly used as prolactin inhibitors. [ 1 ]
Elevated levels of prolactin decrease the levels of sex hormones—estrogen in women and testosterone in men. [16] The effects of mildly elevated levels of prolactin are much more variable, in women, substantially increasing or decreasing estrogen levels.
In women, testosterone is involved in the development and maintenance of lean muscle mass. It also influences how fat is distributed in the body. Low testosterone levels may lead to more fat ...
Cabergoline, sold under the brand name Dostinex among others, is a dopaminergic medication used in the treatment of high prolactin levels, prolactinomas, Parkinson's disease, and for other indications. [3] It is taken by mouth. Cabergoline is an ergot derivative and a potent dopamine D 2 receptor agonist. [4]
Abnormal levels of certain neurotransmitters, such as serotonin Changes in levels of certain hormones, such as prolactin or luteinizing hormone (LH) Mental health issues, such as depression ...
There are few treatments which increase prolactin levels in humans. Treatment differs based on the reason for diagnosis. Women who are diagnosed with hypoprolactinemia following lactation failure are typically advised to formula feed, although treatment with metoclopramide has been shown to increase milk supply in clinical studies.